Overview

  • Product nameSB 297006
  • Description
    Potent, selective CCR3 antagonist
  • Biological descriptionHighly potent, selective CCR3 antagonist (IC50 = 2.5 μM). Displays 250-fold selectivity for CCR3 vs. CXCR1, CXCR2, CCR1 and CCR7 receptors. Potent inhibitor of Ca2+ mobilization induced by eotaxin, eotaxin-2 and MCP-4 in human eosinophils (IC50 values are 210, 90 and 80 nM, respectively).
  • Purity> 99%

Properties

    References for SB 297006 (ab120821)

    This product has been referenced in:
    • Mori A  et al. Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists. Int Immunol 19:913-21 (2007). Read more (PubMed: 17804691) »
    • White JR  et al. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. J Biol Chem 275:36626-31 (2000). Read more (PubMed: 10969084) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120821.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"